AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Treatment Resistant Major Depressive Disorder
The effect is so big that we're seeing, you know, because particularly interesting for a one time thing. And they got there by week three and we're able to like sustain that. I expect that the phase three clinical trials will be even larger, probably expand groups to not only just treatment resistant major depressive disorder but also as an initial monotherapy.